Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has scheduled its fourth quarter fiscal year 2024 financial results announcement for March 11, 2025, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time on the same day, featuring management discussion of results and business updates.
Investors can participate by dialing 1-833-636-0497 and referring to the Bioventus Conference Call. A live webcast and accompanying materials will be available on the company's investor relations website, with replay access until March 10, 2026.
Bioventus (Nasdaq: BVS), leader globale nelle innovazioni per la guarigione attiva, ha programmato l'annuncio dei risultati finanziari per il quarto trimestre dell'anno fiscale 2024 per il 11 marzo 2025, prima dell'apertura del mercato. L'azienda ospiterà una conference call alle 8:30 a.m. ora orientale dello stesso giorno, con una discussione da parte della direzione sui risultati e aggiornamenti aziendali.
Gli investitori possono partecipare componendo il numero 1-833-636-0497 e facendo riferimento alla Conference Call di Bioventus. Una webcast in diretta e materiali correlati saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda, con accesso alla registrazione fino al 10 marzo 2026.
Bioventus (Nasdaq: BVS), líder global en innovaciones para la curación activa, ha programado el anuncio de sus resultados financieros del cuarto trimestre del año fiscal 2024 para el 11 de marzo de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica a las 8:30 a.m. hora del Este el mismo día, con una discusión de la dirección sobre los resultados y actualizaciones del negocio.
Los inversores pueden participar marcando el 1-833-636-0497 y refiriéndose a la Conferencia Telefónica de Bioventus. Una transmisión web en vivo y materiales complementarios estarán disponibles en el sitio web de relaciones con inversores de la empresa, con acceso a la repetición hasta el 10 de marzo de 2026.
Bioventus (Nasdaq: BVS)는 활성 치유를 위한 혁신의 글로벌 리더로서 2024 회계연도 4분기 재무 결과 발표를 2025년 3월 11일 시장 개장 전에 예정하고 있습니다. 회사는 같은 날 오전 8시 30분 동부 표준시(EST)에 경영진이 결과와 사업 업데이트에 대해 논의하는 컨퍼런스 콜을 개최합니다.
투자자는 1-833-636-0497로 전화하여 Bioventus 컨퍼런스 콜을 참조하여 참여할 수 있습니다. 생중계 웹캐스트와 관련 자료는 회사의 투자자 관계 웹사이트에서 제공되며, 2026년 3월 10일까지 재생 접근이 가능합니다.
Bioventus (Nasdaq: BVS), leader mondial en innovations pour la guérison active, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre de l'exercice 2024 pour le 11 mars 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h30, heure de l'Est, le même jour, avec une discussion de la direction sur les résultats et les mises à jour commerciales.
Les investisseurs peuvent participer en composant le 1-833-636-0497 et en faisant référence à la Conférence Téléphonique de Bioventus. Un webinaire en direct et des documents d'accompagnement seront disponibles sur le site web des relations investisseurs de l'entreprise, avec accès à la rediffusion jusqu'au 10 mars 2026.
Bioventus (Nasdaq: BVS), ein globaler Marktführer in der Innovation für aktive Heilung, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal des Geschäftsjahres 2024 für den 11. März 2025 vor der Markteröffnung geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz abhalten, in der die Geschäftsführung die Ergebnisse und Unternehmensaktualisierungen diskutiert.
Investoren können teilnehmen, indem sie die Nummer 1-833-636-0497 wählen und sich auf die Bioventus Telefonkonferenz beziehen. Eine Live-Webcast und begleitende Materialien werden auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit Zugriff auf die Wiederholung bis zum 10. März 2026.
- None.
- None.
DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 10, 2026.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus (BVS) release Q4 2024 earnings?
How can investors join the Bioventus (BVS) Q4 2024 earnings call?
How long will the Bioventus (BVS) Q4 2024 earnings webcast be available?
What time is the Bioventus (BVS) Q4 2024 earnings conference call?
